Literature DB >> 10956656

Occurrence of heparin in the invertebrate styela plicata (Tunicata) is restricted to cell layers facing the outside environment. An ancient role in defense?

M C Cavalcante1, S Allodi, A P Valente, A H Straus, H K Takahashi, P A Mourão, M S Pavão.   

Abstract

Heparin is an intracellular product of vertebrate mast cell currently used as exogenous anticoagulant. Despite of the potent biological activities of exogenous heparin, its physiological function has not been clearly established yet. Here, a heparin with similar structure and anticoagulant properties to the mammalian counterpart was shown to occur as the intracellular product of test cells, a cell monolayer that surrounds egg of the invertebrate Styela plicata (Chordata-Tunicata). As in the case of mammalian mast cells, heparin from the ascidian test cells is removed from the intracellular granules after incubation with compound 48/80. Following fertilization, the test cells surrounding the developing larva still retain heparin as metachromatic granulation. In the adult invertebrate, heparin occurs as intracellular granules at the apical tip of epithelial cells surrounding the lumen of both intestine and pharynx, in close contact with the external environment. This is the first description of the presence of heparin in cytoplasmic granules of epithelial-like cells around the lumen of sites exposed to external agents. This arrangement may reflect the participation of heparin in defense mechanisms in this invertebrate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956656     DOI: 10.1074/jbc.M005830200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Evidence for the heparin-binding ability of the ascidian Xlink domain and insight into the evolution of the Xlink domain in chordates.

Authors:  Masahiko Yoneda; Toshiya Nakamura; Miho Murai; Hiroshi Wada
Journal:  J Mol Evol       Date:  2010-06-26       Impact factor: 2.395

Review 2.  Mast cells and mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Blood       Date:  2008-08-15       Impact factor: 22.113

3.  Evolution of glycosaminoglycans: Comparative biochemical study.

Authors:  Shuhei Yamada; Kazuyuki Sugahara; Suat Ozbek
Journal:  Commun Integr Biol       Date:  2011-03

4.  Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.

Authors:  Tusar K Giri; Douglas M Tollefsen
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

Review 5.  New perspectives on the origins and heterogeneity of mast cells.

Authors:  Ashley L St John; Abhay P S Rathore; Florent Ginhoux
Journal:  Nat Rev Immunol       Date:  2022-05-24       Impact factor: 53.106

6.  Ancient origin of mast cells.

Authors:  G William Wong; Lisheng Zhuo; Koji Kimata; Bing K Lam; Nori Satoh; Richard L Stevens
Journal:  Biochem Biophys Res Commun       Date:  2014-08-02       Impact factor: 3.575

7.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis.

Authors:  Joana C Santos; Juliana M F Mesquita; Celso L R Belmiro; Carolina B M da Silveira; Christian Viskov; Pierre A Mourier; Mauro S G Pavão
Journal:  Thromb Res       Date:  2007-05-04       Impact factor: 3.944

Review 9.  Biological function of unique sulfated glycosaminoglycans in primitive chordates.

Authors:  Konstantina Karamanou; Diana Carolina Restrepo Espinosa; Anneliese Fortuna-Costa; Mauro Sérgio Gonçalves Pavão
Journal:  Glycoconj J       Date:  2016-09-10       Impact factor: 2.916

10.  Our perception of the mast cell from Paul Ehrlich to now.

Authors:  Michael A Beaven
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.